Recombinant EGFR (Matuzumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all EGFR (Matuzumab Biosimilar) products
- EGFR (Matuzumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This EGFR (Matuzumab Biosimilar) antibody is un-conjugated
-
Application
- ELISA
- Purpose
- Matuzumab Biosimilar - Anti-EGFR mAb
- Characteristics
- Antibody Type: IgG1-nd
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG1
-
anti-EGFR (Matuzumab Biosimilar) (Extracellular Domain) antibody
Reactivity: Human BR, FACS, WB Host: Human Monoclonal unconjugated Recombinant Antibody
anti-EGFR (Matuzumab Biosimilar) (Extracellular Domain) antibodyReactivity: Human BR, FACS, WB Host: Rabbit Chimeric unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- EGFR (Matuzumab Biosimilar)
- Abstract
- EGFR (Matuzumab Biosimilar) Products
- Target Type
- Biosimilar
- Background
-
EMD-72000,H425,h425
Matuzumab (formerly EMD 72000) is a humanized monoclonal antibody for the treatment of cancer. It binds to the epidermal growth factor receptor (EGFR) with high affinity. - CAS-No
- 339186-68-4
-
You are here:
